Active Ingredient: EDARAVONE
Proprietary Name: RADICAVA ORS
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 105MG/5ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215446
Product Number: 001
Approval Date: May 12, 2022
Applicant Holder Full Name: MITSUBISHI TANABE PHARMA CORP
Marketing Status:
Prescription
Patent and Exclusivity Information